Drug Type Small molecule drug |
Synonyms Pentetrazol(Balance Therapeutics, Inc.), BTD-001, CARBON-14 (14C)-BTD-001 + [2] |
Target |
Action agonists, stimulants |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), Central nervous system stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC6H10N4 |
InChIKeyCWRVKFFCRWGWCS-UHFFFAOYSA-N |
CAS Registry54-95-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D07409 | 14C-Pentetrazol |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Hypersomnia | Phase 2 | United States | 01 Sep 2015 | |
| Narcolepsy | Phase 2 | United States | 01 Sep 2015 |





